Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Blood biomarkers and quality of life (mean ± SD) following 12 weeks of Active-at-Home-HF

From: Acceptability, Feasibility and Preliminary Evaluation of a Novel, Personalised, Home-Based Physical Activity Intervention for Chronic Heart Failure (Active-at-Home-HF): a Pilot Study

 Pre-interventionPost-interventionP value% change
Cholesterol (mmol/l)4.0 ± 0.93.9 ± 0.90.592.5
Triglyceride (mmol/l)1.5 ± 0.71.8 ± 0.90.4520
HDL (mmol/l)1.2 ± 0.31.1 ± 0.30.678.3
LDL (mmol/l)2.1 ± 0.71.9 ± 0.70.469.5
HbA1c (mmol/mol)49.2 ± 17.347.5 ± 120.773.5
FBG (mmol/l)6.2 ± 2.97.0 ± 3.80.5612.9
NT proBNP (pg/ml)823 ± 1085876 ± 11140.896.4
Renal function eGFR65.4 ± 18.661.4 ± 17.40.616.1
QoL26 ± 1822 ± 230.5015.4
  1. HDL high-density lipoprotein, LDL low-density lipoprotein, HBA1c glycated haemoglobin, FBG fasting blood glucose, NT proBNP N-terminal brain natriuretic peptide, QoL quality of life, eGFR glomerular filtration rate